Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Anesthesia in Fibula Free Flap Reconstruction
NCT03906838Phase 1Withdrawn
- Sponsor
- University of Florida
- Start
- Jan 2020
- Primary completion
- Nov 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by University of Florida. Primary endpoint: Opioid consumption at 72 hours. Planned start Jan 2020; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03906838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03906838.